Find Reports
Select Report Type
Reimbursement Review
Displaying 751 - 775 of 1422
Please scroll or swipe to the right to view the full content.
| Title | Brand Name | Generic Name | Files | Therapeutic Area | Recommendation Type | Status | Submission Date | Recommendation Date Sort ascending | Project Number |
|---|---|---|---|---|---|---|---|---|---|
| Vismodegib (Erivedge) for Adva... | Erivedge | Vismodegib | Basal Cell Carcinoma | Reimburse with clinical criteria and/or conditions | Complete | PC0015-000 | |||
| Trastuzumab emtansine for Meta... | Kadcyla | Trastuzumab emtansine | Advanced or Metastatic Breast Cancer | Reimburse with clinical criteria and/or conditions | Complete | PC0024-000 | |||
| Lurasidone | Latuda | Lurasidone | Schizophrenia | List with criteria/condition | Complete | SR0331-000 | |||
| Somatropin | Genotropin | Somatropin | Growth hormone deficiency, adult | List with criteria/condition | Complete | SR0332-000 | |||
| Somatropin | Genotropin | Somatropin | Growth hormone deficiency, children | List with criteria/condition | Complete | SR0333-000 | |||
| Somatropin | Genotropin | Somatropin | Turner Syndrome | List with criteria/condition | Complete | SR0334-000 | |||
| Ocriplasmin | Jetrea | Ocriplasmin | Vitreomacular adhesion | List with criteria/condition | Complete | SR0337-000 | |||
| Adcetris for systemic Anaplast... | Adcetris | Brentuximab vedotin | Systemic Anaplastic Large Cell Lymphoma | Reimburse with clinical criteria and/or conditions | Complete | PC0021-000 | |||
| Tafinlar for Metastatic Melano... | Tafinlar | Dabrafenib | Metastatic Melanoma | Reimburse with clinical criteria and/or conditions | Complete | PC0025-000 | |||
| Pemetrexed Alimta for Advanced... | Alimta | Pemetrexed | Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer | Reimburse with clinical criteria and/or conditions | Complete | PC0027-000 | |||
| Stivarga for Metastatic Colore... | Stivarga (CRC) | Regorafenib | Metastatic Colorectal Cancer | Do not reimburse | Complete | PC0026-000 | |||
| Ulipristal acetate | Fibristal | Ulipristal acetate | Uterine fibroids | List with criteria/condition | Complete | SR0326-000 | |||
| Saxagliptin | Onglyza | Saxagliptin | Diabetes mellitus, type 2 | List with criteria/condition | Complete | SR0329-000 | |||
| Mekinist for Metastatic Melano... | Mekinist | Trametinib | Metastatic Melanoma | Reimburse with clinical criteria and/or conditions | Complete | PC0030-000 | |||
| Revlimid for Multiple Myeloma ... | Revlimid | Lenalidomide | Multiple Myeloma (as maintenance therapy) | Reimburse with clinical criteria and/or conditions | Complete | PC0029-000 | |||
| Zytiga for Metastatic Castrati... | Zytiga | Abiraterone acetate | Metastatic Castration Resistant Prostate Cancer | Reimburse with clinical criteria and/or conditions | Complete | PC0028-000 | |||
| Linagliptin-metformin | Jentadueto | Linagliptin-metformin | Diabetes mellitus, type 2 | List with criteria/condition | Complete | SR0306-000 | |||
| Perampanel | Fycompa | Perampanel | Epilepsy, partial onset seizures | List with criteria/condition | Complete | SR0316-000 | |||
| Azilsartan medoxomil | Edarbi | Azilsartan medoxomil | Hypertension | Do not list at the submitted price | Complete | SR0317-000 | |||
| Azilsartan medoxomil + chlorth... | Edarbyclor | Azilsartan medoxomil + chlorthalidone | Hypertension | Do not list | Complete | SR0318-000 | |||
| Dimethyl fumarate | Tecfidera | Dimethyl fumarate | Multiple sclerosis, relapsing-remitting | List with criteria/condition | Complete | SR0309-000 | |||
| Everolimus | Afinitor | Everolimus | Renal angiomyolipoma associated with tuberous sclerosis complex (TSC) | Do not list | Complete | SR0315-000 | |||
| Zolpidem tartrate | Sublinox | Zolpidem tartrate | Insomnia | Do not list | Complete | SR0314-000 | |||
| Adcetris for Hodgkin Lymphoma ... | Adcetris | Brentuximab vedotin | Hodgkin Lymphoma | Reimburse with clinical criteria and/or conditions | Complete | PC0020-000 | |||
| Votrient for metastatic renal ... | Votrient | Pazopanib hydrochloride | Metastatic Renal Cell Carcinoma | Reimburse | Complete | PC0022-000 |
Health Technology Review
Displaying 576 - 600 of 600
Horizon Scan
Displaying 101 - 110 of 110
Projects in Progress
Displaying 26 - 27 of 27
View All Reports
Displaying 751 - 775 of 2132
Please scroll or swipe to the right to view the full content.
| Title | Description | Files | Last Updated Sort ascending | Project Line | Project Sub Line | Status | Project Number |
|---|---|---|---|---|---|---|---|
| Transanal Total Mesorectal Excision for Adult Patients with Rectal Cancer | Health Technology Review | Rapid Review | Completed | RC1459-000 | |||
| mogamulizumab | Reimbursement Review | Complete | PC0244-000 | ||||
| abaloparatide | Reimbursement Review | Withdrawn | SR0744-000 | ||||
| Robotic Surgical Systems for Orthopedics | Horizon Scan | Emerging Health Technologies | Completed | EH0108-000 | |||
| Rapid Syphilis Testing | Horizon Scan | Health Technology Update | Completed | EN0043-000 | |||
| Liposuction for Lymphedema | Health Technology Review | Rapid Review | Completed | RC1458-000 | |||
| Oral Feeding for Preterm Infants on Respiratory Support | Health Technology Review | Rapid Review | Completed | RC1461-000 | |||
| Rural Healthcare Planning Initiatives and Frameworks | Health Technology Review | Health Technology Assessment | Completed | HC0044-000 | |||
| Intravenous Iron Isomaltoside for Patients with Iron Deficiency Undergoing Elective Surgery | Health Technology Review | Rapid Review | Completed | RC1456-000 | |||
| Pediatric Glioma Learning Project | Health Technology Review | Technology Review | Active | HM0001-000 | |||
| Evusheld for the Treatment of Mild to Moderate COVID-19 | Health Technology Review | Technology Review | Completed | HC0041-000 | |||
| Azacitidine for Acute myeloid leukemia | Health Technology Review | Technology Review | Completed | HC0036-000 | |||
| Real-Time Continuous Glucose Monitoring: A Review of Guidelines | Health Technology Review | Summary with Critical Appraisal | Completed | RC1449-000 | |||
| sodium phenylbutyrate and ursodoxicoltaurine | Reimbursement Review | Complete | SR0711-000 | ||||
| ruxolitinib | Reimbursement Review | Complete | SR0706-000 | ||||
| upadacitinib | Reimbursement Review | Complete | SR0685-000 | ||||
| selinexor | Reimbursement Review | Complete | PC0276-000 | ||||
| Treatment Strategies for Sexual Dysfunction Associated With Psychotropic Medications | Health Technology Review | Rapid Review | Completed | RC1455-000 | |||
| lenvatinib and pembrolizumab | Reimbursement Review | Complete | PC0268-000 | ||||
| Delayed Tuberculin Skin Testing | Health Technology Review | Rapid Review | Completed | RC1452-000 | |||
| selpercatinib | Reimbursement Review | Complete | PC0274-000 | ||||
| Internet-Delivered Cognitive Behavioural Therapy in the Treatment of Chronic Non-Cancer Pain | Health Technology Review | Optimal Use | Completed | HT0037-000 - OP0550-000 | |||
| Cannabis for Opioid Use Disorder | Health Technology Review | Rapid Review | Completed | RC1454-000 | |||
| lisocabtagene maraleucel | Reimbursement Review | Complete | PG0258-000 | ||||
| Real Time Continuous Glucose Monitoring for People Living with Type 2 Diabetes | Health Technology Review | Rapid Review | Completed | RC1443-000 |